Richard Goldstein, MD
Colon & Rectal Surgery · Langhorne, PANPI 1417948431
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.0% of the total across 42 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Johnson & Johnson at 33.9% of the total. Reporting peaked in 2022 at $308 and has fallen 60.5% since, to $121 in 2025. That places this record below the midpoint for colon & rectal surgery clinicians in PA, where the typical reported total is $2,089.
Across 42 payments — averaging $22.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$324
- Braintree Laboratories, Inc.$236
- Merck$98
- Ferring Pharmaceuticals Inc.$85
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$70
- Shire North American Group Inc$28
- plus $112 from 6 others
What the payments were for
- Food & beverage$87792%
- Gifts$778%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 10 | $324 |
| Braintree Laboratories, Inc. | 9 | $236 |
| Merck | 7 | $98 |
| Ferring Pharmaceuticals Inc. | 5 | $85 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $70 |
| Shire North American Group Inc | 1 | $28 |
| BD | 1 | $24 |
| Coloplast | 1 | $23 |
| Davol Inc. | 1 | $23 |
| Avanos Medical | 1 | $17 |
| Acell, Inc. | 1 | $14 |
| Misonix Inc | 1 | $11 |
How this compares
$954 in reported general payments places this provider in the 35th percentile of 108 colon & rectal surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mesalamine | 42 | $15,676 |
| Mesalamine ErMesalamine | 19 | $4,401 |
| Balsalazide Disodium | 29 | $3,463 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 23 | $292 |
| Fluconazole | 17 | $158 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 24 | $95 |
| Metronidazole | 19 | $80 |
| Metoprolol Tartrate | 13 | $72 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $61 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Langhorne
- Anne-Marie MarcouxLanghorne$2K
- Bogdan ProtyniakWilkes-Barre$429K
- John MarksWynnewood$155K
- Joshua BleierPhiladelphia$86K
- Richard FortunatoPittsburgh$80K
- Najjia MahmoudPhiladelphia$63K
- James McCormickMonroeville$55K
- Juan PoggioPhiladelphia$49K
- Christopher BuzasDanville$25K
- David ZebleyAbington$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.